Pharmaceutical Industry News
Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.
The list of medicines whose export is suspended has been updated
The list of medicines with suspended export guarantees a continuous and safe supply without interruptions over time....
Anvisa publishes a new procedure for medicines
Anvisa has announced new procedures for classifying medicines as over-the-counter or subject to prescription, with a view to regulation....
Anvisa bans phenol in medical and aesthetic treatments
Anvisa bans phenol in health and aesthetics to guarantee the safety and well-being of the Brazilian population....
Framing and reframing the regulation of medicines
New criteria and procedures have been defined for classifying medicines as non-prescription or on prescription....
Anvisa temporarily suspends transfer of ownership
As of this Friday, Solicita will not be making available some issues relating to the transfer of ownership of medicines....
Regulatory Impact Analysis on Cannabis approved
The detailed sector analysis derives suggestions for improving Brazil's medicinal cannabis regulatory framework....
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.